Yifeng Pharmacy
60393925.482.54% ( +0.63 )
Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Yifeng Pharmacy(603939) the Revenue is 6.106 B (+9.73%), Miss estimate;the EBIT is 593.29 M (+15.32%), Beat estimate;the EPS is 0.32 (+14.29%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
6.11B9.73%
6.13B10.15%
-0.02B0.42%
EBITExceed expectations
0.59B15.32%
0.54B4.51%
+0.06B10.81%
EPSMiss expectations
0.3214.29%
0.326816.70%
-0.00682.41%
Upcoming earnings report - FY2026 Annual Earning Release
Available dateApr 27, 2027
Estimate Revenue26.08 B
Estimate EBIT2.747 B
Estimate EPS1.5536
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly